14 Leukemia Clinical Trials in The Bronx, NY (2026)

Q: How do I join a clinical trial in The Bronx?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the The Bronx research site will contact you.

Recruiting Leukemia Studies in The Bronx

NCT07365319Recruiting

A Safety and Efficacy Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Participants With Stage 4 Non-Small Cell Lung Cancer.

This is a study to evaluate the safety and efficacy of EIK1001 administered intravenously in combination with pembrolizumab and histologically appropriate chemotherapy for patients with stage 4 NSCLC....

The Bronx, NYPHASE2750 participantsEikon Therapeutics

View Study Details

NCT07581002Recruiting

A Study to Assess Adverse Events and Change in Disease Activity When Intravenous (IV) Pivekimab Sunirine is Given in Combination With Oral Venetoclax and IV or Subcutaneous Azacitidine in Adult Participants With Acute Myeloid Leukemia (AML)

Cancer is a condition where cells in a specific part of the body grow and reproduce uncontrollably. Acute myeloid leukemia (AML) is a cancer of the blood and bone marrow (the spongy tissue inside the ...

The Bronx, NYPHASE2660 participantsAbbVie

View Study Details

NCT06545331Recruiting

Study of XB010 in Subjects With Solid Tumors

This is a FIH study is to evaluate the safety, tolerability, PK, immunogenicity, and preliminary antitumor activity of XB010 as a single agent and in combination with pembrolizumab in subjects with lo...

The Bronx, NYPHASE1396 participantsExelixis

View Study Details

NCT06745882Recruiting

Prospective Trial Assessing Real World Outcomes Response to Pembro in Black Patients w/ NSCLC

This is a non-registrational, cohort study enrolling eligible Black patients diagnosed with histologically or cytologically, advanced/metastatic NSCLC without known EGFR/ALK/ROS1 tumor mutations, and ...

The Bronx, NYPHASE2318 participantsH. Lee Moffitt Cancer Center and Research Institute

View Study Details

NCT04686305Recruiting

Phase Ib Study of the Safety of T-DXd and Immunotherapy Agents With and Without Chemotherapy in Advanced or Metastatic HER2+, Non-squamous NSCLC

DESTINY-Lung03 will investigate the safety and tolerability of trastuzumab deruxtecan in combination with Immunotherapy Agents with and without chemotherapy in patients with HER2 over-expressing non-s...

The Bronx, NYPHASE1304 participantsAstraZeneca

View Study Details

NCT05304377Recruiting

A Phase 1a/1b Study of ELVN-001 for the Treatment Chronic Myeloid Leukemia

The purpose of this study is to evaluate the safety, tolerability and determine the recommended dose for further clinical evaluation of ELVN-001 in patients with chronic myeloid leukemia with and with...

The Bronx, NYPHASE1250 participantsEnliven Therapeutics

View Study Details

NCT07504458Recruiting

Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia

This Phase 3 study in adult participants with newly diagnosed low-risk APL will evaluate the efficacy, safety, and PK of an oral capsule formulation of ATO, in combination with ATRA....

The Bronx, NYPHASE3150 participantsQuetzal Therapeutics

View Study Details

NCT07070219Recruiting

A Study of CTD402 in T-ALL/LBL Patients

The goal of the TENACITY-01 clinical trial is to learn if CTD402 UCART is safe and effective for relapsed/refractory T-ALL/LBL patients. Participants with relapsed/refractory T-ALL/LBL over the age o...

The Bronx, NYPHASE1118 participantsBIOHENG THERAPEUTICS US LLC

View Study Details

NCT05342584Recruiting

Venetoclax Plus Intensive Chemotherapy in AML and Advanced MDS

This is a Phase 1b, open-label study evaluating Venetoclax in combination with intensive induction and consolidation chemotherapy in previously untreated, adult patients with acute myeloid leukemia. I...

The Bronx, NYPHASE199 participantsMontefiore Medical Center

View Study Details

NCT05184842Recruiting

Metabolically Optimized, Non-cytotoxic Low Dose Weekly Decitabine/Venetoclax in MDS and AML

Myeloid malignancies which include AML (acute myeloid leukemia) and MDS (myelodysplatic syndrome) are cancers of the bone marrow which lead to bone marrow failure. The bone marrow is the place or fact...

The Bronx, NYPHASE291 participantsMontefiore Medical Center

View Study Details

NCT07057791Recruiting

Phase II Study of Platinum/Etoposide Plus Ivonescimab for Extensive-Stage Small Cell Lung Cancer

Eligible untreated participants with Extensive Stage Small Cell Lung Cancer (ES-SCLC) who are ≥ 18 years of age will be randomized to receive ivonescimab 10 milligrams per kilogram (mg/kg) or ivonesci...

The Bronx, NYPHASE260 participantsPrECOG, LLC.

View Study Details

NCT05986240Recruiting

Danvatirsen Monotherapy Followed by Combination With Venetoclax in Relapsed/Refractory MDS & AML

This is a Phase 1 study investigating the safety and efficacy of Danvatirsen as a monotherapy followed by combination with Venetoclax in patients with relapsed/refractory myelodysplastic syndromes (MD...

The Bronx, NYPHASE138 participantsMontefiore Medical Center

View Study Details

NCT07283094Recruiting

FHD-286 With Low-Dose Weekly Decitabine/Venetoclax in Patients With Acute Myeloid Leukemia

This is a Phase 1, uncontrolled, single-arm, open-label, nonrandomized, dose escalation, study of Decitabine (DAC)+Venetoclax (VEN)+FHD-286 in participants with newly diagnosed Acute Myeloid Leukemia ...

The Bronx, NYPHASE133 participantsMontefiore Medical Center

View Study Details

NCT06071624Recruiting

Chimeric Antigen Receptor T Cell Therapy Redirected to CD4 (CD4CAR)as a Second Line Treatment for Chronic Myelomonocytic Leukemia, CMML.

This study is designed as a single arm open label traditional Phase I, 3+3, study of CD4-directed chimeric antigen receptor engineered T-cells (CD4CAR) in subjects with relapsed or refractory CMML. Sp...

The Bronx, NYPHASE130 participantsHuda Salman

View Study Details

About Leukemia Clinical Trials in The Bronx

Leukemia is a group of blood cancers that develop in the bone marrow and result in abnormal white blood cells. Types include acute myeloid (AML), acute lymphoblastic (ALL), chronic myeloid (CML), and chronic lymphocytic (CLL). Treatment varies by type and may include chemotherapy, targeted therapy, and stem cell transplant.

There are currently 14 leukemia clinical trials recruiting participants in The Bronx, NY. These studies are seeking a combined 3,297 participants. Research is being sponsored by Eikon Therapeutics, AbbVie, Exelixis and 8 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Leukemia Clinical Trials in The Bronx — FAQ

Are there leukemia clinical trials in The Bronx?

Yes, there are 14 leukemia clinical trials currently recruiting in The Bronx, NY. Browse the studies on this page to find one that fits.

How do I join a clinical trial in The Bronx?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the The Bronx research site will contact you about next steps.

Are clinical trials in The Bronx free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many The Bronx studies also compensate for your time and travel.

What leukemia treatments are being tested?

The 14 active trials in The Bronx are testing new therapies including novel drugs, biologics, and treatment approaches for leukemia.

Data updated August 31, 2026 from ClinicalTrials.gov